Pharmacogenomics

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco + genomics) reflects it’s combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets). The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

    Related Conference of Pharmacogenomics

    September 24-26, 2018

    14th International Conference on Structural Biology

    Berlin, Germany
    October 03-04, 2018 |

    4th International Conference on Biochemistry & Metabolomics

    Los Angeles, California, USA
    October 18-19, 2018

    10th International Congress on Structural Biology

    Helsinki, Finland
    November 19-20, 2018

    15th World Congress on

    Structural Biology

    Paris, France
    February 28-March 01, 2019

    5th International Conference on Enzymology and Protein Chemistry

    Berlin, Germany
    July 31-August 01, 2019

    6th International Conference on Glycobiology & Glycoproteomics

    Chicago, Illinois, USA

    Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in